Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Oxford U-Flourish student wellbeing survey is part of a longitudinal study evaluating the scope of mental health need among undergraduate students. The study aims to better understand what factors determine student mental health and academic outcomes.

The U-Flourish team is a multidisciplinary group of clinicians, academics and students representing a collaboration between the Oxford Student Union, Oxford University Wellbeing and Support Services, the Department of Psychiatry, University of Oxford and Queen's University, Canada.

The transition to university coincides with a critical period in development, characterised by increased autonomy and responsibility, separation from family and support networks, and development of new social connections. At the same time, the brain is undergoing continued development and individuals are at the peak period of risk for the onset of mental illness. University students are also exposed to a number of unique psychosocial stressors relating to creating new friendship groups, sleep disruption and possibly recreational drug use or alcohol binging. 

 

More students are coming to university with different backgrounds, with varied past experiences, with different expectations, and at the same time emergent adulthood is the peak period of risk for onset of psychiatric illness that will persist if untreated and is associated with school failure and drop-out. Add in substance use and it's this kind of perfect storm of all these risk factors hitting a person right at the most vulnerable time in their development. - Professor Anne Duffy, the study's principal investigator.

 

Emerging research emphasises the substantial unmet need for effective care of students, with international data from the World Health Organisation indicating that up to one-fifth of university students suffer from a year-long mental health disorder. Worryingly, these student's mental health disorders were typically untreated and they were more likely to display higher rates of university drop-out. This further highlights the mounting importance for researchers, clinicians and universities to work together to put in place an evidence-based system of mental health care that meets the needs of students.

Read more about U-Flourish.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

‘Thinking Family’ when an adult has a serious illness

New research shows that although patient’s family details were often recorded, this information was not routinely used to help patients share their diagnosis with children.

Treating mental illness with electricity - new podcast

A new wave of treatments that stimulate the brain with electricity are showing promise on patients and in clinical trials.

Hours of gaming not negatively impacting wellbeing of most adolescents - new study

University of Oxford researchers found that although many school-age adolescents are spending considerable time gaming, it is not having a negative impact on their wellbeing.

Few mental health apps make it to real world, according to new Oxford University study

Despite enthusiasm for digital technology in addressing young people’s mental health, few effective apps have been successfully rolled out.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.

Dementia research - new trial with diabetes drug

An important new trial will test the effects of oral semaglutide on the build-up of a protein in the brain that characterises Alzheimer's disease.